ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET ANONIM SIRKETI Business Segments Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi
Equities
ONCSM
TREONCO00026
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.00 TRY | -4.61% |
|
-19.08% | +0.94% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | |||
Chemotherapy Drug Preparation Sets, Device Sales and Test Kit Sales | 128M | 141M | 241M |
Total Assets | 130M | 167M | 338M |
Interest Expense | -2.61M | -1.12M | -9.87M |
Income Tax Expense | 8.68M | 6.26M | -14.5M |
CAPEX | -10.96M | -13.95M | -27.72M |
EBT | 80.41M | 31.75M | -94.32M |
Gross Profit | 88.34M | 61.3M | 35.79M |
D&A | 8M | 11.11M | 36.67M |
Operating Income | 82.75M | 32.46M | -64M |
Net Income | 71.73M | 25.49M | -79.81M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
Turkey | 92.94M | 124M | 224M |
Overseas | 31.68M | 12.55M | 12.97M |
Unallocated | 3.36M | 3.58M | 3.27M |
MarketScreener is also available in this country: United States.
Switch edition